Deep Track Capital, LP - 03 Apr 2025 SCHEDULE 13G Report for PROTAGONIST THERAPEUTICS, INC. Common Stock, par value $0.00001 (PTGX)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
PROTAGONIST THERAPEUTICS, INC. Common Stock, par value $0.00001
Symbol
PTGX
Shares outstanding
61.4M shares
Disclosed Ownership
3.25M shares
Ownership
5.29%
Form type
SCHEDULE 13G
Filing time
10 Apr 2025, 16:14:54 UTC
Date of event
03 Apr 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 5.29% 3.25M 0 3.25M /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 5.29% 3.25M 0 3.25M /s/ David Kroin David Kroin, Director
David Kroin 5.29% 3.25M 0 3.25M /s/ David Kroin David Kroin